Vitrolife AB (publ)
VTRLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $87,734 | $871,000 | $842,000 | $959,000 |
| % Growth | -89.9% | 3.4% | -12.2% | – |
| Cost of Goods Sold | $42,974 | $366,000 | $359,000 | $373,000 |
| Gross Profit | $44,760 | $505,000 | $483,000 | $586,000 |
| % Margin | 51% | 58% | 57.4% | 61.1% |
| R&D Expenses | $2,417 | $29,000 | $26,000 | $28,000 |
| G&A Expenses | $0 | $130,000 | $115,000 | $142,000 |
| SG&A Expenses | $26,058 | $333,000 | $298,000 | $341,000 |
| Sales & Mktg Exp. | $0 | $203,000 | $183,000 | $199,000 |
| Other Operating Expenses | $0 | $6,000 | $8,000 | -$8,000 |
| Operating Expenses | $28,474 | $368,000 | $332,000 | $361,000 |
| Operating Income | $16,286 | $137,000 | $151,000 | $225,000 |
| % Margin | 18.6% | 15.7% | 17.9% | 23.5% |
| Other Income/Exp. Net | -$2,522 | -$5,000 | -$11,000 | -$42,000 |
| Pre-Tax Income | $13,764 | $132,000 | $140,000 | $183,000 |
| Tax Expense | $3,047 | $32,000 | $41,000 | $43,000 |
| Net Income | $10,717 | $100,000 | $100,000 | $139,000 |
| % Margin | 12.2% | 11.5% | 11.9% | 14.5% |
| EPS | 0.079 | 0.74 | 0.74 | 1.03 |
| % Growth | -89.3% | 0% | -28.2% | – |
| EPS Diluted | 0.079 | 0.74 | 0.74 | 1.02 |
| Weighted Avg Shares Out | 135,423 | 135,423 | 135,423 | 135,423 |
| Weighted Avg Shares Out Dil | 135,423 | 135,423 | 135,423 | 135,709 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,366 | $5,000 | $10,000 | $43,000 |
| Depreciation & Amortization | $11,558 | $0 | $0 | $46,000 |
| EBITDA | $26,793 | $137,000 | $150,000 | $271,000 |
| % Margin | 30.5% | 15.7% | 17.8% | 28.3% |